This thesis describes the synthesis and characterization of metal-encoded polystyrene microspheres with a narrow size distribution designed for mass cytometry-based immuno- and oligonucleotide-assays. These particles were prepared by multiple stage dispersion polymerization techniques using polyvinylpyrrolidone (PVP) as a steric stabilizer. As a cytometeric technique, mass cytometry necessitated metal-encoded microspheres to perform the same roles of fluorescent microspheres used in conventional flow cytometry. The first role of the microsphere was to be able to act as a platform (classifier microspheres) for bioassays. Secondly, the microspheres should be suitable for mass cytometry machine calibration as standards. To perform these roles, metal-encoded microspheres were required to have certain size, functionality and metal content criteria. Lanthanide elements were chosen as the metals for encoding the microspheres for their low natural abundance in biological systems and for their similar chemistry. My goal was to employ two-stage dispersion polymerization, of styrene in ethanol, to introduce the lanthanide salts along with excess acrylic acid in the second stage, one hour after the initiation. Acrylic acid deemed to serve as a ligand for the lanthanide ions, through its carbonyl group, so the lanthanide ions get incorporated into the microsphere while acrylic acid is copolymerizing with styrene. Using two-stage dispersion polymerization, I could synthesize lanthanide encoded microspheres with narrow size distribution and high lanthanide content. However the lanthanide content distributions were unexpectedly much broader than the size distribution obtained. In addition, I could not attach biomolecules to the surface of such particles. In an attempt to improve the characteristics of these microspheres, I employed modified versions of multiple stage dispersion polymerization and seeded emulsion polymerization to grow functional polymer shell on the surface of the particles prepared by dispersion polymerization. Moreover, I coated the lanthanide encoded microspheres with silica shell which enabled me to grow another layer of functional-silica. Consequently, I could use these particles as classifier microspheres for mass cytometry-based immunoassays as well as fluorescence-based oligonucleotide-assays.

Spinal fusion is used to treat diseases or disorders of the spine by fusing together two or more vertebrae. Two associated risks with spinal fusion are infection and blood loss. Administration of tranexamic acid is used to prevent blood loss, and transfusions are given following blood loss. Surgical site infections are prevented with vancomycin powder spread into the surgical wound, while established infections are treated by debridement and delivery of antibiotics for 4 to 6 weeks. The present research explored an alternate method to prevent and treat blood loss or infection in spinal fusion. Poly(lactic-co-glycolic acid) (PLGA) microspheres was used to encapsulate vancomycin for 42 days to treat infection. Vancomycin encapsulated in gelatin microspheres had a controlled release of 7 days to prevent infection. Tranexamic acid was dissolved into phosphate-buffered saline or carboxymethylcellulose to provide a release of 6 hours to prevent blood loss after surgery. The microspheres and tranexamic acid were delivered to a target region using a water based spray system. The spray system demonstrated the delivery and distribution of drugs to a target region. The microsphere spray system is capable of spraying drugs onto a target region to prevent or treat blood loss and infection over time.

The purpose of this research project was to develop and characterise matrix type microspheres prepared from Eudragit® L100, containing insulin as model peptide drug as well as an absorption enhancer, N-trimethyl chitosan chloride (TMC), to improve intestinal absorption via the paracellular route. Insulin loaded microspheres were prepared using a single water in oil emulsification/evaporation method in accordance with a fractional factorial design (23) and subsequently characterised in terms of morphology as well as internal structure. Also, insulin and TMC loading were determined using a high pressure liquid chromatography analysis (HPLC) and colorimetric assay, respectively. Scanning electron microscopic characterisation revealed that most microsphere formulations showed a spherical shape and smooth surface with a sponge-like internal structure as well as relatively good homogeneity in terms of size distribution. Insulin loading ranged from 27.9 ± 14.25 – 52.4 ± 2.72% between the different formulations. TMC loading was lower than for insulin and ranged from 29.1 ± 3.3 - 37.7 ± 2.3% between the different formulations. The pronounced difference in insulin and TMC loading between the microsphere formulations is probably the result of the multitude parameters involved as well as the complex physicochemical processes which govern emulsification/solvent evaporation. Based on the microsphere characterisation results, two formulations were selected (i.e. B and F) for further characterisation (i.e. particle size distribution, dissolution behaviour, and enteric nature) and for in vitro evaluation of insulin transport across excised Fischer (FSR) rat intestinal tissue using a Sweetana-Grass diffusion chamber. Particle size analysis by means of laser light diffraction of the two selected microsphere formulations revealed that the mean particle size (based on volume) ranged from 135.7 ± 41.05 to 157.3 ± 31.74 m. Dissolution results for microsphere Formulations B and F revealed that both insulin and TMC were released from the microsphere formulations in an alkaline environment (pH 7.4). The mean dissolution time (MDT) for insulin ranged from 34.5 ± 4.01 to 42.6 ± 9.06 min, while the MDT for TMC ranged from 1.2 ± 1.73 to 6.8 ± 6.42 min. Statistical analysis revealed no significant differences in the MDT of either insulin or TMC (p-value > 0.05) between the two formulations, although the difference between insulin and TMC of each formulation was significant (p-value < 0.05). Microsphere formulations B and F released 36.92 and 48.21% of their total drug content over a period of 1 h in 0.1 M HCl. Microsphere Formulation B showed 8.3 ± 0.52% and formulation F 8.9 ± 2.26% transport of the initial insulin dose after a period of 120 min across excised rat intestinal tissue. The increase in insulin transport by the microsphere formulations compared to that of the control group (i.e. insulin alone) correlated well with the decrease in transepithelial electrical resistance (TEER) caused by the microsphere formulations. The transport of insulin from Formulations B and F represented transport enhancement ratios of 10.67 and 9.68, respectively. Insulin loaded EudragitL100 microspheres containing TMC were successfully prepared by emulsification/solvent evaporation that demonstrated promising potential to serve as oral drug delivery systems for insulin. The microspheres exhibited improved insulin permeability across intestinal epithelial tissue; however, its enteric properties should be improved and clinical effectiveness need to be confirmed by future in vivo studies. / Thesis (MSc (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

The purpose of this research project was to develop and characterise matrix type microspheres prepared from Eudragit® L100, containing insulin as model peptide drug as well as an absorption enhancer, N-trimethyl chitosan chloride (TMC), to improve intestinal absorption via the paracellular route. Insulin loaded microspheres were prepared using a single water in oil emulsification/evaporation method in accordance with a fractional factorial design (23) and subsequently characterised in terms of morphology as well as internal structure. Also, insulin and TMC loading were determined using a high pressure liquid chromatography analysis (HPLC) and colorimetric assay, respectively. Scanning electron microscopic characterisation revealed that most microsphere formulations showed a spherical shape and smooth surface with a sponge-like internal structure as well as relatively good homogeneity in terms of size distribution. Insulin loading ranged from 27.9 ± 14.25 – 52.4 ± 2.72% between the different formulations. TMC loading was lower than for insulin and ranged from 29.1 ± 3.3 - 37.7 ± 2.3% between the different formulations. The pronounced difference in insulin and TMC loading between the microsphere formulations is probably the result of the multitude parameters involved as well as the complex physicochemical processes which govern emulsification/solvent evaporation. Based on the microsphere characterisation results, two formulations were selected (i.e. B and F) for further characterisation (i.e. particle size distribution, dissolution behaviour, and enteric nature) and for in vitro evaluation of insulin transport across excised Fischer (FSR) rat intestinal tissue using a Sweetana-Grass diffusion chamber. Particle size analysis by means of laser light diffraction of the two selected microsphere formulations revealed that the mean particle size (based on volume) ranged from 135.7 ± 41.05 to 157.3 ± 31.74 m. Dissolution results for microsphere Formulations B and F revealed that both insulin and TMC were released from the microsphere formulations in an alkaline environment (pH 7.4). The mean dissolution time (MDT) for insulin ranged from 34.5 ± 4.01 to 42.6 ± 9.06 min, while the MDT for TMC ranged from 1.2 ± 1.73 to 6.8 ± 6.42 min. Statistical analysis revealed no significant differences in the MDT of either insulin or TMC (p-value > 0.05) between the two formulations, although the difference between insulin and TMC of each formulation was significant (p-value < 0.05). Microsphere formulations B and F released 36.92 and 48.21% of their total drug content over a period of 1 h in 0.1 M HCl. Microsphere Formulation B showed 8.3 ± 0.52% and formulation F 8.9 ± 2.26% transport of the initial insulin dose after a period of 120 min across excised rat intestinal tissue. The increase in insulin transport by the microsphere formulations compared to that of the control group (i.e. insulin alone) correlated well with the decrease in transepithelial electrical resistance (TEER) caused by the microsphere formulations. The transport of insulin from Formulations B and F represented transport enhancement ratios of 10.67 and 9.68, respectively. Insulin loaded EudragitL100 microspheres containing TMC were successfully prepared by emulsification/solvent evaporation that demonstrated promising potential to serve as oral drug delivery systems for insulin. The microspheres exhibited improved insulin permeability across intestinal epithelial tissue; however, its enteric properties should be improved and clinical effectiveness need to be confirmed by future in vivo studies. / Thesis (MSc (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

Leucotrienos e prostaglandinas são metabólitos do ácido araquidônico que, além de mediadores da inflamação são importantes imunomoduladores da liberação de citocinas, nas respostas imune inata e adquirida. Embora estes mediadores apresentem potencial para serem utilizados como adjuvantes ou imunomoduladores da resposta imune, eles são altamente instáveis, dificultando o uso in vivo. Por esta razão, estas substâncias foram incorporadas em um sistema polimérico microestruturado. Este foi constituído de microesferas de quatro a seis micrômetros de diâmetro, contendo leucotrieno B4 (LTB4) ou prostaglandina E2 (PGE2) incorporados na matriz polimérica (PLGA). A caracterização in vitro das microesferas de PLGA, contendo LTB4 ou PGE2, foi feita através da determinação da morfologia e medida dos diâmetros médios, taxa de encapsulação e perfil de liberação in vitro dos mediadores. Além disso, foi avaliada a preservação da atividade biológica do LTB4 liberado das microesferas, através do efeito do mesmo sobre a expressão de moléculas de adesão Mac-1 por citometria de fluxo. Também foram avaliadas a preservação da atividade biológica do LTB4 e da PGE2 liberados do interior das microesferas, através de estudos com microscopia intravital e a ativação de células endoteliais humanas (HUVECs e HUAECs). Realizamos ainda, ensaio de fagocitose com as microesferas contendo os dois mediadores encapsulados, utilizando macrófagos peritoneais murinos, além da avaliação da sobrevivência dos animais tratados intranasalmente com microesferas contendo LTB4 ou PGE2 durante a infecção pelo H. capulatum. Nestes animais, avaliamos a reação inflamatória pulmonar, o número de UFCs recuperadas dos pulmões e a modulação da resposta imune, através da quantificação de citocinas inflamatórias. Os estudos abordados neste trabalho revelaram achados interessantes e importantes quanto ao uso de microesferas biodegradáveis contendo mediadores lipídicos em situação de terapia, especialmente quando estes estão envolvidos em processos inflamatórios e/ou infecciosos. / Leukotrienes and prostaglandins are arachidonic acid metabolites, which participate in the inflammatory response and modulate cytokines release in both adaptive and innate immune responses. However, some physicochemical characteristics of these mediators, such as poor solubility in water and chemical instability, make them difficult to administer in vivo. In this sudy, we developed a polymeric microparticulate system for the encapsulation of lipid mediators. Regarding the in vitro characterization of the microspheres, we determined their diameters, evaluated the in vitro release of the mediators and the microspheres uptake by peritoneal macrophages. To assess the preservation of the biological activities of these mediators, we conducted intravital microscopy studies and determined the effect of LTB4 and PGE2-loaded biodegradable microspheres on inflammatory mediators release by murine peritoneal macrophages and human endothelial cells. In mice infected by H. capsulatum, we investigated the effects of intranasal administration of the microspheres on pulmonary inflammatory response. In this context, we analyzed the inflammatory cells recruited to the bronchoalveolar space, the mice survival and the number of CFUs recovered from the lungs after the administrations. We also assessed the cytokines release by the lung cells after the treatment with microspheres during the course of the infection. In conclusion, our findings showed that biodegradable microspheres could preserve the biological activity of the encapsulated mediators indicating their use as a new strategy to modulate cell activation, especially in the innate immune response.

O crescimento de células em arcabouços tridimensionais porosos tem se tornado progressivamente ativo na engenharia de tecidos. Os arcabouços guiam o crescimento celular, sintetizam uma matriz extracelular e outras moléculas biológicas, e facilitam a formação de tecidos e órgãos funcionais. Um cimento deste tipo pode ser preparado misturando um sal de fosfato de cálcio com uma solução aquosa para que se forme uma pasta que possa reagir à temperatura corporal dando lugar a um precipitado que contenha hidroxiapatita (Ca10(PO4)6(OH)2). A similaridade química e morfológica entre este biomaterial e a parte mineral dos tecidos ósseos permite a osteocondução, sendo o cimento substituído por tecido ósseo novo com o tempo e com a vantagem de não desencadear processos inflamatórios e de corpo estranho, com eventual expulsão do material implantado. O objetivo do presente trabalho foi a obtenção e caracterização de suportes tridimensionais para a engenharia de tecido, com o uso de matérias-primas nacionais, por meio da utilização de microesferas de parafina como corpos geradores de poros. As microesferas foram produzidas por suspensão em solução aquosa de poli (álcool vinílico) (PVA) e sulfato de sódio (Na2SO4). Foram analisadas as fases presentes no cimento sintetizado e após a reação de cura do mesmo, a variação do tamanho de partícula e da resistência mecânica com o tempo de moagem. Foi analisada a porosidade dos suportes e a forma de extração da parafina daqueles que a utilizaram na sua formação. O tamanho de poro dos suportes gerados com a variação da quantidade de fase líquida ficou aquém do tamanho considerado ideal para o crescimento de tecido ósseo. A porosidade dos arcabouços fabricados com esferas de parafina foi observada por microscopia eletrônica de varredura (MEV), e seu comportamento foi analisado a partir de ensaios in vitro em solução SBF (simulated body fluid) e em cultura de células. A utilização de esferas de parafina permitiu a formação de poros com tamanho tal que possibilitam potencialmente o crescimento tecidual e celular. / The growth of cells in three-dimensional porous scaffolds has been extensively studied for use in tissue engineering. They guide grow of cells, synthesize extra cellular matrix and other biological molecules, and facilitate the formation of functional tissues and organs. Bone cements has been developed for biomedical applications for a decade approximately. This kind of cement can be prepared mixing a calcium phosphate salt with aqueous solution forming a paste that can react at body temperature generating a hydroxyapatite precipitated (Ca10(PO4)6(OH)2). The chemical and morphological similarity between the cement composition and the mineral part of the bones allows osteoconduction in the tissue with replacement of cement by new bone formed with the advantage to not unchain inflammatory processes and of strange body. The objective of this work was the use of the α-TCP cement for making these scaffolds, through the variation of the amount of liquid phase in the cement and of the use of paraffin spheres as pore source. These spheres were produced by suspension in water solution of poly (vinyl alcohol) and sodium sulphate (Na2SO4). The phases had been analyzed in the synthesized cement and after the reaction of cure of cement, beyond variation of the particle size and the resistance mechanics with the milling time. It was analyzed the porosity of the scaffolds and the extraction of the paraffin in that supports. The pore size of the supports generated with the variation of the amount of liquid phase was on this side of the size considered ideal for the bone tissue growth. The porosity of scaffolds manufactured with paraffin spheres was observed by Scanning Electron Microscopy (SEM), and its behavior was analyzed from test in vitro in SBF solution (simulated body fluid). The use of paraffin spheres allowed the formation of pores size able to permit tissue growth.

xi, 125 p. : ill. (some col.) A print copy of this thesis is available through the UO Libraries. Search the library catalog for the location and call number. / This dissertation presents experimental and theoretical studies of radiation pressure cooling in silica optomechanical microresonators where whispering gallery modes (WGMs) are coupled to thermal mechanical vibrations. In an optomechanical system, circulating optical fields couple to mechanical vibrations via radiation pressure, inducing Stokes and anti-Stokes scattering of photons. In analogy to laser cooling of trapped ions, the mechanical motion can in principle be cooled to its ground state via the anti-Stokes process in the resolved-sideband limit, in which the cavity photon lifetime far exceeds the mechanical oscillation period. Our optomechanical system is a slightly deformed silica microsphere (with a diameter 25-30 μm ), featuring extremely high Q -factors for both optical ( Q o ∼ 10 8 ) and mechanical ( Q m ∼ 10 4 ) systems. Exploiting the unique property of directional evanescent escape in the deformed resonator, we have developed a free-space configuration for the excitation of WGMs and for the interferometric detection of mechanical displacement, for which the part of input laser that is not coupled into the microsphere serves as a local oscillator. Measurement sensitivity better than 5 × 10 -18 m /[Special characters omitted.] has been achieved. The three optically active mechanical modes observed in the displacement power spectrum are well described by finite element analysis. Both radiation pressure cooling and parametric instabilities have been observed in our experiments. The dependence of the mechanical resonator frequency and linewidth on the detuning as well as the intensity of the input laser show excellent agreement with theoretical calculations with no adjustable parameters. The free-space excitation technique has enabled us to combine resolved sideband cooling with cryogenic cooling. At a cryogenic temperature of 1.4 K, the sideband cooling leads to an effective temperature as low as 210 m K for a 110 MHz mechanical oscillator, corresponding to an average phonon occupation of 37, which is one of the three lowest phonon occupations achieved thus far for optomechanical systems. The cooling process is limited by ultrasonic attenuation in fused silica, which should diminish when bath temperature is further lowered, with a 3 He cryostat, to a few hundred millikelvin. Our experimental studies thus indicate that we are tantalizingly close to realizing the ground-state cooling for the exploration of quantum effects in an otherwise macroscopic mechanical system. / Committee in charge: Michael Raymer, Chairperson, Physics; Jens Noeckel, Member, Physics; Hailin Wang, Member, Physics; Paul Csonka, Member, Physics; Jeffrey Cina, Outside Member, Chemistry

xii, 138 p. : ill. (some col.) A print copy of this thesis is available through the UO Libraries. Search the library catalog for the location and call number. / Controlling colloidal interactions continues to receive a great deal of attention due both to basic scientific interests as well as industrial applications. However, many aspects of interactions between microparticles remain poorly understood, including the attraction observed between particles with the same kind of charge (like-charge attraction). This situation hinders progress in the generation of colloidal self-assembled structures. This thesis focuses on measurements of pair interactions of functionalized silica microspheres and the resulting insights into colloidal interactions. Silica microparticles were functionalized in two ways. For one method, each particle was coated with a lipid inlayer membrane. The charge density of the particle surface can thereby be easily tuned by controlling the type or amount of charged lipids. For the other method, the cholera toxin subunit B protein (CTB) was bound to lipid-functionalized microparticles. To measure pair interactions, we invented a line optical trap that enables nearly free one-dimensional Brownian motion of particles. Pair interaction energies of functionalized particles above the bottom of the experimental chamber can be extracted via a Boltzmann relationship. Both lipid-only and lipid-plus-protein functionalized microparticles show tunable, attractive pair interactions. For lipid-only coatings, the attraction becomes stronger by increasing the fraction of positively charged lipids. There is a linear relationship between pair potential and molar percentage of positively charged lipids. For lipid-plus-protein coatings, attractive potentials were weakened monotonically by binding more CTB. Decompositions of potential curves allow identification of directly charge-dependent and charge-independent contributions to colloidal like-charge attraction. Analysis shows that the correlations between attraction strength and range are opposite in these two sets of particles. Moreover, the correlations between particle-wall separation and attraction strength in lipid-only and lipid-plus-protein functionalized particles are also opposite. These comparisons show that like-charge attraction may result from more than one mechanism. Finally, we measured pair potential energies of lipid functionalized silica particles above a lipid functionalized glass chamber bottom, which exhibit a quadratic relationship between the attraction strength and the fraction of positively charged lipids. Compared with the situation of particle functionalization only, this relation indicates that confinement-induced like-charge attraction can be modulated by altering electrostatic properties of the confining wall. / Committee in charge: Dr. Stephen D. Kevan, Chair; Dr. Raghuveer Parthasarathy, Advisor; Dr. Hailin Wang; Dr. Miriam Deutsch; Dr. Marina G. Guenza

O objetivo do presente estudo foi sintetizar e caracterizar um material reparador para uso endodôntico com propriedades anti-inflamatória, antimicrobiana e remineralizante. A pasta experimental tem como propósito ser um sistema carreador de fármacos para regiões de difícil acesso em Odontologia. A apresentação do material é em forma de pó:líquido. No pó se encontra α-fosfato tricálcico, tungstato de cálcio e microesferas de amoxicilina (AMX-MS), já no líquido estão contidas nanocápsulas de indometacina (IndOHNC). A pasta experimental foi testada em relação a suas características físicoquímicas e biológicas. As AMX-MS obtiveram tamanho de 1,604 μm ± 0,08, forma esférica confirmada por MEV e teor da droga foi 1,63 mg g-1. As IndOHNC obtiveram tamanho de 162 ± 7,5 nm e forma esférica confirmada por MET. O teor do fármaco foi de 1 mg mL-1 ± 0,02. O escoamento da pasta foi de 18.56 ± 0.29, a espessura de película obtida foi 33 μm e radiopacidade de 1,81 mmAl. A pasta experimental demonstrou atividade antibacteriana contra o Enterococcus faecalis. A maior concentração de pasta experimental apresentou o maior valor em relação à viabilidade celular, com 187,03% no teste SRB. A atividade da enzima fosfatase alcalina e a formação de nódulos mineralizados obtiveram um gradual aumento em função do tempo. A migração celular demonstrou fechamento da ferida, e a pasta experimental foi capaz de acelerar o processo (p<0.05). Em conclusão, a pasta experimental demonstrou propriedades físico químicas e biológicas confiáveis, podendo ser um material promissor para o reparo da região periapical. / The aim of this study was to synthesize and characterize a new reparative material with anti-inflammatory, antimicrobial and remineralizing properties. The reparative material was developed to be a drug delivery system for regions with difficult access in Dentistry. The formulation is presented in powder/liquid. The powder is composed of α-tricalcium phosphate, calcium tungstate and amoxicillin microspheres (AMX-MS). The liquid is composed of nanocapsules containing indomethacin (IndOH-NC). The physicochemical and biological properties of the experimental endodontic paste were evaluated. The AMX-MS obtained a mean size of 1.604 μm ± 0.08, spherical shape and the encapsulation capacity was 1.63 mg g-1. IndOH-NCs obtained a mean size of 162 ± 7.5 nm and spherical shape confirm by MET. The content of the encapsulated drug was 1 mg mL-1 ± 0.02. The experimental paste flow was 18.56 ± 0.29 mm, mean film thickness was 33 μm and radiopacity equivalent to 1.81 mmAl. The experimental paste showed antibacterial activity against Enterococcus faecalis. The highest concentration of experimental paste presented the highest value in cell viability (187.03% in SRB test). The activity of the phosphatase alkaline enzyme and the formation of mineralized nodules showed a gradual increase as a function of time. Cell proliferation showed continuous wound closure, and the experimental paste was able to accelerate the process (p<0.05). In conclusion, the experimental paste demonstrated reliable physicochemical and biological properties, and it could be a promising material for periapical region repair.

A esquistossomose é uma doença parasitária aguda e crônica causada por vermes sanguíneos (vermes nematoides) do gênero Schistosoma. O homem contrai a esquistossomose através da penetração ativa da cercaria na pele. A importância do tratamento desta enfermidade consiste não só no fato de curar a doença ou diminuir a carga parasitária dos pacientes, bem como impedir sua evolução para formas mais graves. Para o tratamento da esquistossomose o fármaco de escolha é o praziquantel; isso se deve ao seu amplo espectro, sua eficácia, segurança e a relação custo/tratamento. A única forma farmacêutica disponível no Brasil é o comprimido, na dose de 600 mg, a qual pode ser subdividida em quatro partes de 150 mg, a fim de facilitar o ajuste de dose. No entanto, no momento da subdivisão dos comprimidos ocorre o rompimento do revestimento. Este fato acaba levando a uma exposição do fármaco e, consequentemente, de seu sabor amargo. Esta característica dificulta a administração do medicamento, principalmente na população infantil, prejudicando o tratamento e o controle da doença. Uma alternativa para este problema é o desenvolvimento de sistemas poliméricos microparticulados que associados ao fármaco impediriam o contato direto com as papilas gustativas e assim promoveriam uma melhoria na palatabilidade. Para isso utilizou-se a técnica modificada de deposição interfacial do polímero pré-formado seguido de secagem por aspersão. Três matrizes poliméricas, com diferentes características de liberação foram utilizadas, Eudragit RL 100 – liberação tempo dependente e Eudragit E100 e L30D-55 – liberação pH dependente. Além disso, dois tipos de sistemas carreadores do fármaco foram preparados, microcápsulas e microesferas poliméricas. Estes sistemas obtidos foram avaliados e caracterizados a fim de eleger a melhor proposta de formulação visando o mascaramento do sabor do fármaco. De acordo com os resultados obtidos selecionou-se um sistema composto por microcápsulas formadas a partir do polímero L30D-55. A partir de então inseriu-se este sistema na forma farmacêutica pó para suspensão oral, onde diferentes propostas de formulações, contendo dois edulcorantes auxiliares, aspartame e sacarina, separadamente, e seus respectivos placebos foram avaliadas através de um método in vitro para a determinação do sabor, a língua eletrônica ou sensor gustativo. As diferentes formulações avaliadas apresentaram capacidade em mascarar o sabor desagradável do fármaco e, assim resultam em uma promissora alternativa para o aumento da adesão por parte dos pacientes à terapêutica, principalmente para crianças, em virtude da facilidade de administração, do ajuste da dose em função da massa corpórea e ao sabor muito mais agradável ao paladar infantil. / Schistosomiasis is a parasitic disease acute and chronic caused by blood worms (nematodes worms) of the genus Schistosoma. Man acquires schistosomiasis through the active penetration of the worms in skin. The importance of treatment of this disease is not only the fact of curing the disease or decreases the parasite load of patients, well as prevent progression to more severe forms. For the treatment of schistosomiasis praziquantel is the drug of choice, this is due to its wide spectrum, its efficacy, safety and the relation cost / treatment. The single dosage form available in Brazil is tablet at a dose of 600 mg, which can be subdivided into four parts of 150 mg to facilitate dose adjustment. However when the subdivision of the tablets occurs the disruption of the coating. This fact provides a drug exposure and consequently of its bitter taste. This characteristic complicates the administration of the drug mainly in children, affecting the treatment and control of disease. An alternative for this problem is the development of microparticulate polymeric systems which associated with the drug would prevent direct contact with the taste buds and thus promote an improvement in palatability. For this was used a modified technique interfacial deposition of preformed polymer followed by spray drying. Three polymer matrices with different release characteristics have been used, Eudragit RL 100 – time dependent release, and Eudragit E100 and L30D-55 – pH dependent release. Furthermore, two types of drug carrier systems have been prepared, polymeric microspheres and microcapsules. These systems obtained were evaluated and characterized in order to select the best proposal formulation aimed at masking the taste of the drug. According to the results we selected a system comprising microcapsules formed from L30D-55 polymer. From then was inserted into this system in the pharmaceutical form, powder for oral suspension, where different proposals formulations containing two auxiliary sweeteners, aspartame and saccharin, separately, and their respective placebos were evaluated in an in vitro method for determining the taste, the electronic tongue. The different formulations tested presented excellent ability to mask the unpleasant taste of the drug and thus present an excellent alternative for increasing adherence to therapy, especially for children, because of the ease of administration, according on dose adjustment of body mass and the much more palatable to children's taste.